[Indications and practical management of parenteral iron therapy].
Absolute or functional iron deficiency is a common problem in chronic disease which may lead to iron-deficient erythropoesis. Moreover, lack of available iron is the most common reason for unresponsiveness to epoetin in patients on chronic dialysis. Measurements of serum ferritin, transferrin saturation and percentage of hypochromic red blood cells allow the assessment of iron status. Lack of iron resorption and dose-dependent side-effects limit oral supplementation in a number of patients. Several iron preparations are available for intravenous substitution, especially the newly registered iron-saccharose offers safe and reliable iron supplementation and reduces the risk of anaphylaxis and iron toxicity. This review discusses new guidelines concerning diagnosis of iron status, indication for therapy and application of intravenous iron preparation.
Kosch
Markus
M
Medizinische Poliklinik und Poliklinik D, Universitäts-Klinikum Münster, Münster, Deutschland.
Schaefer
Roland M
RM
D000284:Administration, Oral; D000328:Adult; D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D002648:Child; D004906:Erythrocyte Count; D004920:Erythropoiesis; D005260:Female; D005290:Ferric Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D000077605:Ferric Oxide, Saccharated; D005293:Ferritins / Q000097:blood; D005937:Glucaric Acid; D006801:Humans; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D000090463:Iron Deficiencies; D008297:Male; D006435:Renal Dialysis / Q000009:adverse effects; D013395:Sucrose / Q000008:administration & dosage*; D013997:Time Factors; D014168:Transferrin / Q000032:analysis
D005290:Ferric Compounds; D014168:Transferrin; D013395:Sucrose; D005293:Ferritins; D000077605:Ferric Oxide, Saccharated; D005937:Glucaric Acid; C035552:ferric gluconate